NCT02320864

Brief Summary

To evaluate operational aspects of studying pre to post surgery/hospitalization changes in the integrity of a major white matter pathways and how these contribute to reductions in the ability to produce forceful muscle contractions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 31, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

April 5, 2018

Status Verified

April 1, 2018

Enrollment Period

2.9 years

First QC Date

July 31, 2014

Last Update Submit

April 4, 2018

Conditions

Keywords

muscle strengthmuscle weaknesshospitalizationsurgerytotal knee replacement

Outcome Measures

Primary Outcomes (2)

  • muscle strength

    We will measure plantar extension/flexion and knee extension/flexion strength using Isokinetic dynamometry (Biodex Inc., Shirley, NY). To prevent injury, participants will be secured to a padded chair using a lap and shoulder belts. To become accustomed to the testing machine, participants will first perform leg extensions with a light force applied to the target limb. Testing will commence after a short rest period that will be used to administer instruction and address any participant questions. Participants will perform 2 sets of each exercise for 15 repetitions at velocities of 60 degrees per second and 120 degrees per second. Tests will be done on both right and left sides and the maximal force will be determined. A 2-3 minute rest will be given between each set of exercise.

    Change in baseline, 3 months and 12 months

  • Muscle mass

    Dual-energy X-ray absorptiometry (DEXA) whole body scan will be used to assess lean and fat mass of the lower extremity (Hologic, Discovery QDR Series, Bedford, MA). Participants will be asked to lie still on a table for approximately10 minutes while the scan is acquired by a certified technician.

    Change in baseline, 3 months and 12 months

Secondary Outcomes (4)

  • Short physical performance batter score (SPPB)

    Change in baseline, 3 months and 12 months

  • 6-minute walk distance

    Change in baseline, 3 months and 12 months

  • Spatiotemporal gait characteristics

    Change in baseline, 3 months and 12 months

  • Brain MRI derived corticospinal tract integrity from foot motor cortex to cerebral peduncle

    Change in baseline, 3 months and 12 months

Other Outcomes (2)

  • perceived pain

    Change in baseline, 3 months and 12 months

  • physical activity

    Change in baseline, 3 months and 12 months

Study Arms (2)

Non-surgical group

Adults who have knee osteoarthritis, but do not elect to have a total knee replacement surgery.

Surgical group

Adults who have knee osteoarthritis and elect to have total knee replacement surgery.

Procedure: Total knee replacement surgery

Interventions

The surgeon removes damaged cartilage and bone from the surface of the knee joint and replaces them with a man-made surface of metal and plastic.

Surgical group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will comprise two age-matched participant groups: 1.) 'Healthy' non-demented (n=20) patients undergoing elective total knee arthroplasty, and 2.) age, education, and disease matched (osteoarthritis knee pain; n=20) non-surgery peers. We expect to screen 60 potential participants to yield 40 participants who complete the protocol. All participants will be recruited with the assistance of the Orthopedic Surgery Department at UFHealth. The parallel control group will originate from the parent study physician. Only right-handers will participate in this experiment because left-handedness is associated with greater variability in white matter organization and cognitive functions.

You may qualify if:

  • Aged 60 years old or older with no upper limit at time of baseline assessment
  • Right handed; restriction due to left-right hemisphere laterality and white matter pathways
  • Able to understand and speak English
  • Willing to give informed consent

You may not qualify if:

  • Any conditions that pose health risk with physical exertion during a strength test as discovered on a medical history (e.g. heart failure, surgical complications etc.)
  • Cancer requiring treatment in past 5 years (exception: non-melanoma skin cancer)
  • Serious infectious diseases (e.g., self-reported HIV, sepsis)
  • Myocardial infarction/ CVA within last six months
  • Congestive heart failure (NY stage III or IV)
  • Chronic hepatitis
  • History of organ transplantation
  • Seizure disorders
  • History of head trauma resulting in intensive care
  • Current diagnosis of alcoholism
  • Drug dependence, or a history of major tranquilizer use
  • History of major stroke(s)
  • Exposure to toxins or neuroleptics
  • History of encephalitis
  • Neurological signs of upper motor neuron disease, cerebellar involvement, supranuclear palsy, or orthostatic hypertension that causes fainting
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute on Aging

Gainesville, Florida, 32611, United States

Location

MeSH Terms

Conditions

OsteoarthritisSarcopeniaMuscle Weakness

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsMuscular DiseasesPathologic Processes

Study Officials

  • Todd M Manini, Ph.D.

    University of Florida

    PRINCIPAL INVESTIGATOR
  • Adam J Woods, Ph.D.

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2014

First Posted

December 19, 2014

Study Start

July 1, 2014

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

April 5, 2018

Record last verified: 2018-04

Locations